Economic Impact of Acinetobacter baumannii Infection in the Intensive Care Unit

This publication has 10 references indexed in Scilit:

• Cost-effectiveness of Implementing Low-Tidal Volume Ventilation in Patients With Acute Lung Injury
  Chest, 2009
• Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach
  American Journal of Infection Control, 2009
• Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
  Infection Control & Hospital Epidemiology, 2008
• Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes
  European Journal of Clinical Microbiology & Infectious Diseases, 2007
• Clinical and Economic Impact of Multidrug Resistance in Nosocomial Acinetobacter baumannii Bacteremia
  Infection Control & Hospital Epidemiology, 2007
• Attributable Mortality of Nosocomial Acinetobacter Bacteremia
  Infection Control & Hospital Epidemiology, 2007
• Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of Hospitalization
  Emerging Infectious Diseases, 2007
• The Cost of Antibiotic Resistance: Effect of Resistance Among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on Length of Hospital Stay
  Infection Control & Hospital Epidemiology, 2002
• Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
• Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients
  Critical Care Medicine, 1999